All In Biotech

Drug Trial Radar · NCT01912677

Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy

Last checked: Nov 19, 2026Latest source record: Nov 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 894 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

894

Actual

Start

Apr 2015

Primary completion

Sep 2017

Study completion Dec 2017

Sponsor

Lead sponsor
Gynuity Health ProjectsAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Government Medical College, Nagpur; Daga Memorial Women's Hospital, Nagpur, India; University of British Columbia; Bill and Melinda Gates Foundation
First posted
Jul 31, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a pragmatic, open-label, randomised control trial of three oral anti-hypertensive regimens for women with severe hypertension in pregnancy. Women presenting with severe hypertension in pregnancy in two hospitals in Nagpur, India will be randomised to one of three oral regimens: nifedipine, labetalol or methyldopa. This trial will compare the efficacy, safety and side effects of these three oral regimens for management of hypertension in pregnant women. The investigators hypothesize that nifedipine treatment of severe hypertensive parturient women is more effective than treatment with labetalol or methyldopa in controlling high blood pressure within six hours.

Conditions

  • Hypertension in Pregnancy
  • Preeclampsia

Interventions

  • NifedipineDrug

  • LabetalolDrug

  • MethyldopaDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful outcomeTime frame: 6 hours

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Daga Women's Hospital

    Nagpur, Maharashtra, India

  • Government Medical College

    Nagpur, Maharashtra, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.